Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice

Background. Slow-acting symptomatic agents (chondroprotectors) in osteoarthritis (OA) combined therapy is a promising approach. Aim. To compare the real-world results of combined therapy with glycosaminoglycan-peptide complex (GPC) and diacerein with GPC monotherapy in treating knee OA. Materi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Andrey E. Karateev, Elena Iu. Polishchuk, Alena S. Potapova, Elena V. Matyanova, Ekaterina S. Filatova, Svetlana I. Glukhova, Aleksander M. Lila
Format:	Artigo
Idioma:	Russo
Publicat:	ZAO "Consilium Medicum" 2023-05-01
Col·lecció:	Consilium Medicum
Matèries:	osteoarthritis glycosaminoglycan-peptide complex diacerein combination efficacy safety
Accés en línia:	https://consilium.orscience.ru/2075-1753/article/viewFile/553441/132691
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!